Results 101 to 110 of about 263,626 (317)

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Additional file 4: of Blood transcriptomics of drug-naĂŻve sporadic Parkinsonâ s disease patients

, 2015
Square of the Mahalanobis distance calculated for each sample from both control and pathological class models. (PDF 3122 kb)
Calligaris, Raffaella, Banica, Mihaela, Roncaglia, Paola, Robotti, Elisa, Finaurini, Sara, Vlachouli, Christina, Antonutti, Lucia, Iorio, Francesco, Carissimo, Annamaria, Cattaruzza, Tatiana, Ceiner, Andrea, Lazarevic, Dejan, Cucca, Alberto, Pangher, Nicola, Marengo, Emilio, Bernardo, Diego Di, Pizzolato, Gilberto, Gustincich, Stefano   +17 more
openaire   +1 more source

Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy. [PDF]

, 2009
In synucleinopathies, including Parkinson's disease, partially ubiquitylated alpha-synuclein species phosphorylated on serine 129 (P(S129)-alpha-synuclein) accumulate abnormally.
Goujet-Zalc Cécile, Paleologou Katerina, Vitte Jérémie, Duchateau, René, Corti, Olga, Hamon Michel, Perez-Diaz, Fernando, Fournier Margot, Fernando Perez-Diaz, Saurini, Françoise, Traver, Sabine, Katerina Paleologou, Joubert, Chantal, Hilal A Lashuel, Christian Haass, Philipp J Kahle, Jean-Philippe Dullin, Charles Duyckaerts, Joubert Chantal, Garrigue Jérôme, Ardila-Osorio Héctor, Langui, Dominique, Michel Hamon, Jérémie Vitte, Margot Fournier, Cornilleau Fabien, Paleologou, Katerina, Duyckaerts Charles, Hanoun Naïma, Françoise Saurini, Corti Olga, Cécile Goujet-Zalc, Kahle Philipp J., Fabien Cornilleau, Haass Christian, Alexis Brice, Naïma Hanoun, Kahle, Philipp J., Cohen-Salmon, Charles, Dullin, Jean-Philippe, Fournier, Margot, Olga Corti, Hamon, Michel, Chantal Joubert, Vitte, Jérémie, René Duchateau, Cohen-Salmon Charles, Dominique Langui, Héctor Ardila-Osorio, Kahle, Philipp J, Traver Sabine, Cornilleau, Fabien, Lashuel Hilal A., Duchateau René, Jérôme Garrigue, Ardila-Osorio, Héctor, Langui Dominique, Garrigue, Jérôme, Haass, Christian, Lashuel, Hilal A., Brice Alexis, Duyckaerts, Charles, Brice, Alexis, Charles Cohen-Salmon, Perez-Diaz Fernando, Sabine Traver, Lashuel, Hilal A, Saurini Françoise, Goujet-Zalc, Cécile, Dullin Jean-Philippe, Hanoun, Naïma   +70 more
core   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao, Rong Li, Yu‐Xiang Jiao, Kai Ma, Hong‐Qi Yang, Zheng‐Yu Sun, Jie‐Wen Zhang, Shuai Chen   +7 more
wiley   +1 more source

MOESM3 of A randomized controlled efficacy study of the Medido medication dispenser in Parkinsonâ s disease

, 2019
Additional file 3. Table with secondary outcomes of UPDRS-4.
Hannink, K., Brake, L., Oonk, N.G.M., Wertenbroek, A.A., Piek, M., Vree-Egberts, L., Faber, M.J., Palen, J., Dorresteijn, L.D.   +8 more
openaire   +1 more source

Parkinson’s Disease and the Dental Patient

, 2019
Parkinson’s disease is a chronic, age-related, and progressive neurodegenerative disease of the CNS that causes numerous motor and non-motor symptoms. The oral and dental health of its patients can suffer tremendously. Therefore, it is the responsibility
Safar, Fadi Raad Munir
core  

Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

Background Accurate definition and operational criteria for diagnosing Parkinson’s disease (PD) are crucial for evidence-based, patient-centered care.
Becktepe, Jos, German Parkinson’s Guidelines Group, Berg, Daniela, Höglinger, Günter, Deuschl, Günther, Hopfner, Franziska, Ceballos-Baumann, Andrés, Deuschl, Cornelius, Trenkwalder, Claudia, Bähr, Mathias, Claßen, Joseph, Brockmann, Kathrin   +11 more
core   +1 more source

Difference in cardiovascular response during orthostatic stress in Parkinson’s disease and multiple system atrophy [PDF]

, 2020
Although orthostatic hypotension is more prominent in multiple system atrophy (MSA) than in Parkinson’s disease (PD), there is no study comparing the degree of decrease in total peripheral resistance and cardiac response during orthostatic stress between
Harada, Yumiko, Ueda, Masamichi, Nakamura, Tomohiko, Hirayama, Masaaki, Katsuno, Masahisa, Suzuki, Masashi   +5 more
core   +1 more source

ALDOA Promotes Glycolysis and NLRP3/GSDMD Pyroptosis to Accelerate ALS Progression

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration. Glycolytic dysregulation is implicated in disease progression, yet the underlying mechanisms remain unclear. This study investigates how Aldolase A (ALDOA) drives ALS progression through glycolysis‐mediated motor neuron pyroptosis.
Kaixin Yan, Yan Jiang, Yuxuan Yong, Tianshuo Zhang, Niannian Zhang, Qianqian Zeng, Xue Gong, Li Meng, Fangfang Bi, Yongmin Liu   +9 more
wiley   +1 more source

MOESM1 of A randomized controlled efficacy study of the Medido medication dispenser in Parkinsonâ s disease

, 2019
Additional file 1. Table with secondary outcomes of PDQ-39.
Hannink, K., Brake, L., Oonk, N.G.M., Wertenbroek, A.A., Piek, M., Vree-Egberts, L., Faber, M.J., Palen, J., Dorresteijn, L.D.   +8 more
openaire   +1 more source